Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 18;19(1):1.
doi: 10.1007/s11934-018-0757-4.

Perianesthetic Management of Laparoscopic Kidney Surgery

Affiliations
Review

Perianesthetic Management of Laparoscopic Kidney Surgery

Georges Nasrallah et al. Curr Urol Rep. .

Abstract

Purpose of review: Laparoscopic kidney surgery is commonly used for living donor, partial, and total tumor nephrectomy. The successful emergence of laparoscopic technique was justified by the many benefits offered such as reduced blood loss, tissue trauma, pain, and hospital stay. However, this comes at the expense of physiologic changes and complications secondary to pneumoperitoneum, surgical technique, and patient positioning with significant challenges in anesthetic management.

Recent findings: A variety of laparoscopic approaches (transperitoneal, retroperitoneal, hand-assisted, robotic) are used with some having advantages over others. The kidneys are particularly sensitive to hemodynamic changes and pneumoperitoneum. Controversies in perioperative fluid administration exist. New modalities for postoperative pain control have been suggested. Laparoscopic kidney surgery is associated with multiple physiologic changes and adverse events but offers advantages of reduced postoperative pain, faster recovery, and shorter hospital stay. Understanding these physiologic changes and related anesthetic considerations is key for safe patient outcome.

Keywords: Donor nephrectomy; Laparoscopy anesthesia; Laparoscopy complications; Partial nephrectomy; Pneumoperitoneum: physiological effects.

PubMed Disclaimer

References

    1. Clin Transplant. 2001;15 Suppl 6:59-61 - PubMed
    1. Transplant Proc. 2011 Dec;43(10):3588-92 - PubMed
    1. Drugs. 2015 Nov;75(16):1867-89 - PubMed
    1. Transplantation. 2014 Jan 27;97(2):161-7 - PubMed
    1. Surg Endosc. 2017 Feb;31(2):501-503 - PubMed

LinkOut - more resources